(Q37371312)

20 August 2017

1 reference

title

Management of hypertension in angiogenesis inhibitor-treated patients (English)

1 reference

20 August 2017

main subject

arterial hypertension

0 references

patient

0 references

angiogenesis inhibitor

1 reference

4

J C Soria

0 references

author name string

H Izzedine

1

1 reference

20 August 2017

S Ederhy

2

1 reference

20 August 2017

F Goldwasser

3

1 reference

20 August 2017

G Milano

5

1 reference

20 August 2017

A Cohen

6

1 reference

20 August 2017

D Khayat

7

1 reference

20 August 2017

J P Spano

8

1 reference

20 August 2017

publication date

15 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

20

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

807-815

1 reference

Prognostic importance of comorbidity in a hospital-based cancer registry

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Fat distribution, body mass index and blood pressure in 22 090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Re: damien pouessel, stéphane culine. High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor. Eur urol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Reversible posterior leukoencephalopathy syndrome and bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Hypertension associated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Sunitinib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Sorafenib for the treatment of advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer In

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Home blood-pressure monitoring in patients receiving sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

VEGF inhibition and renal thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN713

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN713

1 reference

20 August 2017

1 reference